Liraglutide
利拉鲁肽
Report date: 2026/05/20 20:02:01
Base Information
Drug NameLiraglutide
Drug Alias Name +[13]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[36]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2009/06/30
Country/Territory +[52]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNational Institutes Of HealthBiolingusNovo Nordisk Inc +[13]
Inactive CompaniesArmy Medical University, ChinaEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentUniversity Of Manitoba +[25]
Active Indications +[12]
Inactive Indications +[24]